XRF Scientific reported revenue of $59.5 million, down slightly from $60.1 million in FY24 (a 1.1% decrease). Despite this, the company achieved a record Net Profit After Tax, up 17% year-on-year, driven by strong divisional performance and margin improvements.

Reasons for Slight Revenue Decline

1. Capital Equipment: Sales of xrFuse fusion machines normalized after prior years of strong growth, leading to fewer new orders.
2. Precious Metals: Fewer large new metal orders compared to FY24, though recurring orders remained strong.
3. Consumables: Record product volumes were offset by falling lithium input prices, which lowered selling prices and slightly reduced top-line revenue.

Divisional Highlights

• Consumables: Achieved a record profit before tax of \$7.2 million.
• Precious Metals: Delivered \$21.5 million in revenue and \$3.6 million in profit before tax.
• Capital Equipment: Generated \$21.8 million in revenue and \$4.6 million in profit before tax.
• Orbis Mining: Contributed \$5.8 million in revenue and \$1.7 million in profit before tax, with full ownership acquired post-year-end[1].

Balance Sheet & Financial Position

• Cash Position: Ended FY25 with \$8.13 million in cash, down from \$12.05 million in FY24[2].
• Borrowings: Total debt reduced slightly to \$4.57 million from \$4.69 million in FY24. Financing costs declined due to reduced borrowings[3].
• Net Cash: Net cash position decreased to \$3.56 million, down from \$7.35 million in FY24.
• Major Cash Outflows: Included the \$2 million purchase of the remaining Orbis shares and a \$4.1 million dividend payment during the year.

Shareholder Returns

• Declared a final fully franked dividend of 4.5 cents per share, up 15% from the previous year